Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
151
NCT00518401
Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2007
Completion: Oct 31, 2009
NCT00548613
Combination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium
Start: Oct 31, 2007
Completion: Mar 31, 2009
NCT00643981
Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia
Start: Feb 29, 2008
Completion: Feb 28, 2009
NCT00721006
Phase II Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia
Phase: Phase 2
Start: Jun 30, 2008
Completion: Sep 30, 2010
NCT00790764
Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI)
Start: Nov 30, 2008
Completion: May 31, 2014
NCT01082653
Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
Start: Mar 31, 2010
NCT01162915
Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury
Start: Jul 31, 2010